Thus, according to the WHO 2021 classification, a diffuse glioma exhibiting microvascular proliferation or necrosis, along with an IDH mutation, is classified not as glioblastoma (GBM), but as grade 4 astrocytoma (ASTROG4) [1-6]. The gene discussed is IDH1; the disease is glioblastoma.